Connect your AI

KMTS KMTS Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Boston ScientificBSX

——

MedtronicMDT

——

iRhythm Holdings, Inc. IRTC

——

Merit Medical SystemsMMSI

——

HaemoneticsHAE

——

ICU MedicalICUI

——

Other financials

Income statement

Revenue$24.6M+62.7%

Gross profit$12.9M+97.1%

Operating income-$34.8M-68.8%

Net income-$34.2M-58.8%

EPS (diluted)-$0.61+51.2%

Balance sheet

Cash & equivalents$291.3M+436%

Total debt$43.8M—

Total assets$379.3M—

Cash flow

Operating cash flow-$18.4M-2.1%

CapEx$9.8M+141%

Free cash flow-$28.2M-27.7%

Valuation

Market cap$1.32B+70.8%

Enterprise value$1.07B—

P/S15.7×—

Profitability

Gross margin48.8%+15.1pp

Operating margin-171.5%+12.9pp

Net margin-173%+0.8pp

FCF margin-142.9%-25.3pp

Returns & leverage

Current ratio7.3×—

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is KMTS's software and technology licenses, net?: KMTS (KMTS) reported software and technology licenses, net of $5.88M in Q4 2025.